A.J Hospital and Research Centre Elevates Patient Safety Standards in Mangalore with Dozee’s AI- Based Continuous Remote Patient Monitoring and Early Warning System

A. J. Hospital and Research Centre, Mangalore, one of the foremost tertiary hospitals in India has announced the adoption of Dozee’s advanced AI-based Contactless and continuous Remote Patient Monitoring (RPM) and Early Warning System (EWS). This implementation showcases A.J Hospital and Research Centre’s commitment to leveraging “Made in India’ technology for enhanced patient safety, continuum of care, and to elevate overall patient care standards.

Next-Generation Ambulatory Connected Monitoring Systems

The Non-ICU ward beds in A.J Hospital and Research Centre equipped with next-generation ambulatory connected patient monitoring systems enabling contactless continuous vitals monitoring and an Early warning alert system by Dozee. Dozee’s solution is cloud-enabled and comes with a central and remote patient monitoring capability that empowers healthcare providers to monitor the patient continuously and more effectively to provide timely medical interventions for improved patient safety and clinical outcomes. Automation and digitalization of vital data and operational processes are significant for A.J Hospital and Research Centre in its journey to provide Quality healthcare to every Indian.

Dozee enables healthcare workers to remotely monitor patients’ vital parameters such as heart rate, respiration rate, blood pressure, SPO2 levels, temperature, and ECG. Dozee’s Early Warning System (EWS) tracks the trends of vital parameters and provides alerts to healthcare providers for early detection of patients’ clinical deterioration, enabling timely medical intervention. Dozee uses AI-based Ballistocardiography (BCG) for contactless vitals monitoring. Dozee’s technology is patented and made in India. Dozee’s innovative technology significantly impacts patient safety, clinical outcome, and operational efficiency. Research done by independent consulting firm Sattva shows that for every ~100 Dozee connected beds, it can save ~144 lives and ~80% of the time taken for vitals by nurses and reduce ICU ALOS by ~1.3 days.

Dr. Prashanth Marla

Dr. Prashanth Marla, Medical Director of A.J Hospital & Research Centre, asserted the hospital’s unwavering commitment to redefining the landscape of patient safety in Mangalore. He declared, “A.J Hospital and Research Centre’s strategic partnership with Dozee is our bold step towards establishing unparalleled benchmarks in patient safety. We are not just adopting technology; we are shaping the future of healthcare innovation. Mangalore can now expect a new era where cutting-edge technology harmonizes with compassionate care, setting a powerful example for the entire region.”

“Our collaboration with A.J Hospital and Research Centre signifies a joint endeavor to set a precedent in the Mangalore market, establishing new standards of patient safety. Our ‘Made-in-India’ technology is not just a solution; it’s a commitment to excellence, a force majeure in reshaping patient monitoring. This partnership exemplifies our shared commitment to revolutionize patient care and safety. ” added Mr. Mudit Dandwate, CEO and Co-Founder, Dozee

A.J Hospital and Research Centre’s adoption of Dozee showcases their commitment to pioneering healthcare solutions, elevating patient safety standards in Mangalore through AI-based continuous remote patient monitoring and early warning system.

SourceDozee

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”